ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol

June 14, 1991

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

Nancy Brinker Resigns As CEO of Komen

August 10, 2012